home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Arcus Biosciences, Inc. Common Stock (NY:RCUS)

21.80 +0.01 (+0.05%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcus Biosciences, Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Earnings Scheduled For May 9, 2022 ↗

May 09, 2022

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.

Via Benzinga

Arcus Biosciences's Earnings Outlook ↗

May 06, 2022

Arcus Biosciences (NYSE:RCUS) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Arcus...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 05, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Arcus Biosciences to Report First Quarter 2022 Financial Results and Pipeline Update

April 26, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

April 26, 2022

From Arcus Biosciences

Via Business Wire

4 Undervalued Biotech Stocks to Add to Your Buy List ↗

April 20, 2022

These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.

Via InvestorPlace

Arcus Biosciences Announces New Employment Inducement Grants

April 11, 2022

From Arcus Biosciences, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

April 11, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...

Via Benzinga

51 Biggest Movers From Yesterday ↗

April 06, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...

Via Benzinga

30 Stocks Moving In Tuesday's Mid-Day Session ↗

April 05, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 139% to $5.40 after the company announced that two of its designed mRNA molecules are effective at destroying...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 163.3% to $5.95 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel ↗

April 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

18 Stocks Moving in Tuesday's Pre-Market Session ↗

April 05, 2022

Gainers System1, Inc. (NYSE: SST) rose 37.5% to $22.70 in pre-market trading as the company reported a 48% year-over-year surge in Q4 sales and issued strong sales forecast....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 05, 2022

Good morning, investor! It's time to start off another busy day of trading with the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

Arcus Biosciences Announces New Employment Inducement Grants

March 24, 2022

From Arcus Biosciences, Inc.

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

February 24, 2022

From Arcus Biosciences, Inc.

Via Business Wire

88 Biggest Movers From Yesterday ↗

February 25, 2022

Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...

Via Benzinga

Recap: Arcus Biosciences Q4 Earnings ↗

February 23, 2022

Arcus Biosciences (NYSE:RCUS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

February 23, 2022

From Arcus Biosciences, Inc.

Via Business Wire

Arcus Biosciences's Earnings: A Preview ↗

February 22, 2022

Arcus Biosciences (NYSE:RCUS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

"Prudent" Biotech Bets ↗

February 20, 2022

Here, we review two recommended biotechnology stocks following the release of their latest earnings reports. Let's take a look.

Via Talk Markets

Arcus Biosciences to Participate in the Upcoming Investor Conferences

February 15, 2022

From Arcus Biosciences

Via Business Wire

Earnings Scheduled For February 23, 2022 ↗

February 23, 2022

Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

February 09, 2022

From Arcus Biosciences

Via Business Wire

Gilead Stock Dives After Two Major Charges Dig Into Fourth-Quarter Earnings ↗

February 01, 2022

Gilead shares toppled after hours on lighter-than-expected fourth-quarter profit.

Via Investor's Business Daily

Arcus Biosciences Announces New Employment Inducement Grants

January 25, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

January 11, 2022

From Arcus Biosciences, Inc.

Via Business Wire

Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones

January 10, 2022

From Arcus Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 04, 2022

Gainers Oncternal Therapeutics (NASDAQ:ONCT

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com